AIVITA Biomedical CEO Dr. Hans Keirstead to speak at Exponential Medicine
IRVINE, Calif. – November 6, 2017 – AIVITA Biomedical CEO Dr. Hans Keirstead is scheduled to speak at Exponential Medicine, a biomedical and technology conference taking place November 6-9 at the Hotel del Coronado in San Diego. Dr. Keirstead’s talk will take place Tuesday, November 7th and will focus broadly on the future of regenerative medicine. He will also speak with spinal cord injury patient advocate Roman Reed in a session about cutting-edge research in the field.
Exponential Medicine is a unique and intensive four-day experience that gathers world-class faculty, innovators and organizations from across the biomedical and technology spectrum to explore and leverage the convergence of fast moving technologies in the reinvention and future of health and medicine.
Dr. Keirstead, a pioneer of the regenerative medicine industry, began his career with a graduate thesis that constituted the first demonstration of functional regeneration of the injured adult spinal cord. He has invented and overseen the development of stem cell-based treatments for spinal cord injury, spinal muscular atrophy, amyotrophic lateral sclerosis, retinal diseases such as macular degeneration, and cancer.
About AIVITA Biomedical
AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline. Sales of AIVITA’s skin care products support its clinical development efforts, including a platform cancer immunotherapy.